Zacks Investment Research on MSN
Investors heavily search CRISPR Therapeutics AG (CRSP): Here is what you need to know
CRISPR Therapeutics AG (CRSP) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to ...
Aurora Therapeutics, cofounded by Nobel Prize–winning scientist Jennifer Doudna, plans to use gene editing and a new FDA ...
Earlier this month, CRISPR Therapeutics presented at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco, ...
A new CRISPR breakthrough shows scientists can turn genes back on without cutting DNA, by removing chemical tags that act ...
Innovative research into the gene-editing tool targets influenza’s ability to replicate—stopping it in its tracks.
The need to change regulations around gene-editing treatments was endorsed in November by the head of the US Food and Drug ...
A new CRISPR approach can control genes without cutting DNA, opening a safer path for treating genetic diseases. A newly ...
CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, today highlighted its strategic priorities and anticipated ...
Scientists have used CRISPR to give the goldenberry a modern makeover, shrinking the plant by about a third and making it ...
The study used large-scale CRISPR gene-editing technology to systematically determine which genes are required as embryonic ...
A live webcast of the presentation will be available on the "Events & Presentations" page in the Investors section of the ...
Across all domains of life, immune defenses foil invading viruses by making it impossible for the viruses to replicate. Most ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results